High-potency active pharmaceutical ingredient (HPAPI) CDMO capacity — the containment manufacturing for oncology cytotoxics, hormone disruptors, and compounds with occupational exposure limits below 10 µg/m³ creating the most technically demanding and capacity-constrained segment in pharmaceutical outsourcing — creates the most commercially dynamic market segment, with...